Investigating Implant Surface Effect on Osseointegration: NGA vs. ModSLA

ConditionDental Implant

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorBarts & The London NHS Trust

About this trial

This study aims to characterise the stability of crestal bone levels one year after loading, the associated aesthetic outcomes, immunological response, prosthodontic outcomes as well as overall patient reported outcome measures for modSLA (SLActive, Institut Straumann AG, Switzerland) and NGA (TiUltraNP, Nobel Biocare AG, Switzerland) dental implants.

Eligibility criteria

Qualifiers

Age: over 18 years old,

Gender: male and female.

Patient must be able and willing to follow study procedures and instructions and have capacity to provide informed consent.

Patient must require tooth extraction of a maxillary first premolar or single-rooted anterior tooth as the result of caries, endodontic failure or trauma

Disqualifiers

Systemic disease that can interfere with dental implant therapy (e.g. uncontrolled diabetes)

2 adjacent teeth requiring extraction

Greater than one wall of the socket missing - assessed at time of extraction

Any contraindications for oral surgical procedures

Trial design

Treatments tested in this trial

Implant Type

Treatment groups

39 Participants

are divided into 3 treatment groups

Sponsors and collaborators

Barts & The London NHS Trust

Lead sponsor

Virginia Commonwealth University

Collaborator

Source ClinicalTrials.gov